ARTV vs AAPL: Which Stock is Better?
Side-by-side comparison of Artiva Biotherapeutics Inc and Apple Inc in 2026
ARTV
Artiva Biotherapeutics Inc
$10.80
AAPL
Apple Inc
$271.65
Key Metrics Comparison
| Metric | ARTV | AAPL | Winner |
|---|---|---|---|
| Market Cap | $253.10M | N/A | ARTV |
| P/E Ratio | N/A | 34.35 | AAPL |
| EPS (TTM) | $N/A | $7.90 | AAPL |
| Revenue Growth | -1.0% | 0.2% | AAPL |
| Gross Margin | 0.0% | 47.3% | AAPL |
Analyze ARTV
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ARTV or AAPL a better investment?
Comparing ARTV and AAPL: Artiva Biotherapeutics Inc has a market cap of $253.10M while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ARTV and AAPL?
ARTV (Artiva Biotherapeutics Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ARTV or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ARTV or AAPL?
AAPL has higher revenue growth at 0.2% vs -1.0% for ARTV.
Which company is more profitable: ARTV or AAPL?
Apple Inc (AAPL) has higher gross margins at 47.3% compared to 0.0% for ARTV.
Which is the larger company: ARTV or AAPL?
Artiva Biotherapeutics Inc (ARTV) is larger with a market cap of $253.10M compared to N/A for AAPL.
Should I buy ARTV or AAPL in 2026?
Both ARTV and AAPL have investment merit. ARTV trades at $10.80 while AAPL trades at $271.65. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ARTV and AAPL stock?
Key differences: Market Cap ($253.10M vs N/A), P/E Ratio (N/A vs 34.3x), Revenue Growth (-1.0% vs 0.2%), Gross Margin (0.0% vs 47.3%).